Diagnosis and management of Zollinger-Ellison syndrome.
With the recent widespread availability of gastrin radioimmunoassays, the development of increasingly effective medical therapy for gastric hypersecretion, and improved methods to localize gastrinomas in patients with Zollinger-Ellison syndrome, the diagnosis, treatment of the gastric acid hypersecretion, and approach to the tumor have changed significantly. Recent advances in each of these areas and the current management of a patient with Zollinger-Ellison syndrome are reviewed.
Maton
P N
PN
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Gardner
J D
JD
Jensen
R T
RT
D006801:Humans; D015043:Zollinger-Ellison Syndrome / Q000175:diagnosis* / Q000628:therapy